Advertisement · 728 × 90
#
Hashtag
#genethon
Advertisement · 728 × 90
Video

[ESGCT CONGRES]
🎉 Du 7 au 10 octobre, @genethonfr.bsky.social sera à l'honneur lors du congrès #ESGCT2025 à Séville !
🔬 4 présentations orales, 19 posters – 2 sessions co-présidées.
🌍 Rencontrons-nous!
👉Actualité : urlr.me/aWVrAE
#Genethon #DMD #MaladiesRares #Recherche

1 0 0 0
Video

[ESGCT CONGRESS]
🎉 From Oct 7–10, @genethonfr.bsky.social
takes center stage at #ESGCT2025 in Seville!
🔬 4 oral presentations, 19 contributions – 2 co-chaired sessions
🌍 Let’s connect, share & inspire!
👉Read the full news : urlr.me/G9t7mv
#Genethon #DMD #RareDiseases #Research

1 0 0 0
Video

📢 Genethon is now on Bluesky! 🚀
We’re excited to expand our presence and join the Bluesky #community to share updates on our latest breakthroughs in gene therapy.
👉Follow us to stay informed about our innovations, research, and mission!

#Genethon #GeneTherapy #Bluesky #Innovation #Science

6 1 0 0
Genethon Expects to Begin Phase 3 Trials of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy in 2025 in Europe, Followed by US

Genethon Expects to Begin Phase 3 Trials of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy in 2025 in Europe, Followed by US

Genethon Expects to Begin Phase 3 Trials of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy in 2025 in Europe, Followed by US

#dmd #duchenne #bmd #becker
#genetherapy #dmdwarrior #dmdwarriors #duchennewarriors #duchenne #musculardystrophy #gene #dna #genethon #gnt0004 #europe #2025

0 0 1 0
Preview
Genethon and Hansa Biopharma Launch Revolutionary Gene Therapy Trial for Rare Syndromes Genethon and Hansa Biopharma have begun a Phase 2 trial to examine imlifidase as a pre-treatment for gene therapy targeting Crigler-Najjar syndrome, enhancing patient access.

Genethon and Hansa Biopharma Launch Revolutionary Gene Therapy Trial for Rare Syndromes #Sweden #Lund #Hansa_Biopharma #Genethon #imlifidase

0 0 0 0
GNT004 Duchenne Muscular Dystrophy

GNT004 Duchenne Muscular Dystrophy

Genethon’s CEO, Frederic Revah discusses how the drug candidate GNT004 has the potential of becoming best-in-class gene therapy for DMD (Duchenne Muscular Dystrophy).

Source: www.youtube.com/watch?v=YtTX...

#dmd #bmd #hope #science
#genetherapy #dmdwarrior #dmdwarriors #genethon #gnt0004

1 0 0 0
La minute #Téléthon: Le #Genethon et l'Institut de #Myologie! #shorts #don #santé #médecine
La minute #Téléthon: Le #Genethon et l'Institut de #Myologie! #shorts #don #santé #médecine YouTube video by Instant Stress

La minute #Téléthon: Le #Genethon et l'Institut de #Myologie! #shorts #don #santé #médecine youtube.com/shorts/mrZJQ...

0 0 0 0
Post image Post image

Genethon Presents Positive Initial Results from a Phase 1/2/3 Trial of its Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy at ASGCT Breakthroughs in Muscular Dystrophy in Chicago

Source: bit.ly/3ZiNRdp

#genethon #gnt0004 #dmd #duchenne #dmdwarrior #genetherapy

0 0 0 0